NDTVCenter·
Novartis Drug Fails Key Test For New Heart Disease Approach
Amgen and Eli Lilly & Co. are testing their own drugs to lower Lp(a), though they're further behind in development.
Read at NDTV →
Business · 1 sources covering this
Novartis Drug Fails Key Test For New Heart Disease Approach
Amgen and Eli Lilly & Co. are testing their own drugs to lower Lp(a), though they're further behind in development.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/1eb6ad6270a125cd48095d2e8fdaf4bffdbc5d3a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novartis Drug Fails Key Test For New Heart Disease Approach"></iframe>
